Filing metadata

Accession number
0001209191-23-021905
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Mar 31, 2023
Reporting period
Mar 29, 2023
Description
Insider transaction

Explore SEC Filings Hub